Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes
Authors:
- 1 March 2015
- journal article
- Published by SAGE Publications in Acta Radiologica
- Vol. 56 (3) , 269-275
Abstract
Background: Breast cancer is a heterogeneous disease with intrinsic molecular subtypes. The different biology and histology of breast cancer exhibit different tumor morphology at breast magnetic resonance imaging (MRI). However, few studies have examined the quantitative relationship between the MRI morphological and immunohistochemical features in breast cancer. Purpose: To investigate the correlations between tumor roundness, as quantitatively assessed with MRI and biomarkers or subtypes of breast cancer. Material and Methods: A total of 280 women (mean age, 51 years; range, 28–79 years) with 282 invasive breast cancers (<5 cm) were included. The associations between the tumor roundness (1–100%), as measured using MRI software, and immunohistochemical (e.g. estrogen receptor [ER], progesterone receptor [PR], human epidermal growth factor receptor 2 [HER2], and Ki67) features were evaluated using Pearson’s or Spearman’s rank correlation coefficients and multiple linear regression analysis. Results: An inverse correlation was observed between the ER (r = –0.408, P < 0.001) or PR (r = –0.248, P < 0.001) scores and tumor roundness, whereas a positive correlation was observed between the Ki67 index and tumor roundness (r = 0.354, P < 0.001). In multiple linear regression, the ER score ( P < 0.001) and Ki67 index ( P = 0.003) were independent factors determining tumor roundness. Triple-negative tumors (ER, PR, and HER2 negative) showed the highest mean roundness scores compared with the other subtypes (e.g. 67.3% for triple-negative, relative to 55.9% for HER2-enriched, 53.8% for luminal B, and 51.7% for luminal A, P < 0.001). Conclusion: Our results suggest that breast tumors with lower ER expression and higher cellular proliferation or biologically aggressive triple-negative tumors are likely to manifest with relatively benign morphologic features.Keywords
This publication has 28 references indexed in Scilit:
- Correlations between diffusion-weighted imaging and breast cancer biomarkersEuropean Radiology, 2012
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer SubtypeJournal of Clinical Oncology, 2011
- Metastatic Behavior of Breast Cancer SubtypesJournal of Clinical Oncology, 2010
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- Cancer Yield of Mammography, MR, and US in High-Risk Women: Prospective Multi-Institution Breast Cancer Screening StudyRadiology, 2007
- Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast CancerJournal of Clinical Oncology, 2005
- Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapyEuropean Radiology, 2004
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Molecular portraits of human breast tumoursNature, 2000